{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:26:31Z","timestamp":1790616391101,"version":"4.1.0"},"reference-count":27,"publisher":"China Science Publishing & Media Ltd.","issue":"3","license":[{"start":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T00:00:00Z","timestamp":1550534400000},"content-version":"vor","delay-in-days":18,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["2009ZRB019N0"],"award-info":[{"award-number":["2009ZRB019N0"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2019,2,1]]},"DOI":"10.1093\/abbs\/gmy177","type":"journal-article","created":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T12:07:57Z","timestamp":1546430877000},"page":"293-300","update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":27,"title":["Liraglutide alleviates cardiac fibrosis through inhibiting P4hα-1 expression in STZ-induced diabetic cardiomyopathy"],"prefix":"10.3724","volume":"51","author":[{"given":"Tong","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2019,2,19]]},"reference":[{"key":"null","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s00125-014-3171-6","volume":"57","author":"Bugger H","year":"2014","unstructured":"Bugger H, Abel ED. Molecular mechanisms of diabetic cardiomyopathy. Diabetologia, 2014, 57: 660-671.","journal-title":"Diabetologia"},{"key":"null","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.pharmthera.2014.01.003","volume":"142","author":"Huynh K","year":"2014","unstructured":"Huynh K, Bernardo BC, McMullen JR, Ritchie RH. Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways. Pharmacol Ther, 2014, 142: 375-415.","journal-title":"Pharmacol Ther"},{"key":"null","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.yjmcc.2015.12.011","volume":"90","author":"Russo I","year":"2016","unstructured":"Russo I, Frangogiannis NG. Diabetes-associated cardiac fibrosis: cellular effectors, molecular mechanisms and therapeutic opportunities. J Mol Cell Cardiol, 2016, 90: 84-93.","journal-title":"J Mol Cell Cardiol"},{"key":"null","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1172\/JCI108843","volume":"60","author":"Regan TJ","year":"1977","unstructured":"Regan TJ, Lyons MM, Ahmed SS, Levinson GE, Oldewurtel HA, Ahmad MR, Haider B. Evidence for cardiomyopathy in familial diabetes mellitus. J Clin Invest, 1977, 60: 885-899.","journal-title":"J Clin Invest"},{"key":"null","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/eht193","volume":"35","author":"Wong TC","year":"2013","unstructured":"Wong TC, Piehler KM, Kang IA, Kadakkal A, Kellman P, Schwartzman DS, Mulukutla SR. Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission. Eur Heart J, 2013, 35: 657-664.","journal-title":"Eur Heart J"},{"key":"null","first-page":"219","volume":"102","author":"Factor SM","year":"1981","unstructured":"Factor SM, Bhan R, Minase T, Wolinsky H, Sonnenblick EH. Hypertensive-diabetic cardiomyopathy in the rat: an experimental model of human disease. Am J Pathol, 1981, 102: 219-228.","journal-title":"Am J Pathol"},{"key":"null","doi-asserted-by":"crossref","first-page":"e85078","DOI":"10.1371\/journal.pone.0085078","volume":"9","author":"van Bilsen M","year":"2014","unstructured":"van Bilsen M, Daniels A, Brouwers O, Janssen BJ, Derks WJ, Brouns AE, Munts C. Hypertension is a conditional factor for the development of cardiac hypertrophy in type 2 diabetic mice. PLoS One, 2014, 9:","journal-title":"PLoS One"},{"key":"null","doi-asserted-by":"crossref","first-page":"380","DOI":"10.2337\/diabetes.52.2.380","volume":"52","author":"Kjems LL","year":"2003","unstructured":"Kjems LL, Holst JJ, V\u00f8lund A, Madsbad S. The influence of GLP-1 on glucose-stimulated insulin secretion: effects on \u03b2-cell sensitivity in type 2 and nondiabetic subjects. Diabetes, 2003, 52: 380-386.","journal-title":"Diabetes"},{"key":"null","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.intimp.2014.07.010","volume":"22","author":"Si G","year":"2014","unstructured":"Si G, Tao Z, Wei W, Min X, Wang X.-C., Chen Z.-H.. Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-\u03baB in mice. Int Immunopharmacol, 2014, 22: 498-504.","journal-title":"Int Immunopharmacol"},{"key":"null","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/cen.12369","volume":"81","author":"Kahal H","year":"2014","unstructured":"Kahal H, Abouda G, Rigby A, Coady A, Kilpatrick E, Atkin S. Glucagon-like peptide-1 analogue, liraglutide, improves liver fibrosis markers in obese women with polycystic ovary syndrome and nonalcoholic fatty liver disease. Clin Endocrinol (Oxf), 2014, 81: 523-528.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"null","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/1479164115605000","volume":"13","author":"Gaspari T","year":"2016","unstructured":"Gaspari T, Brdar M, Lee HW, Spizzo I, Hu Y, Widdop RE, Simpson RW. Molecular and cellular mechanisms of glucagon-like peptide-1 receptor agonist-mediated attenuation of cardiac fibrosis. Diab Vasc Dis Res, 2016, 13: 56-68.","journal-title":"Diab Vasc Dis Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1210\/endo.137.7.8770921","volume":"137","author":"Bullock BP","year":"1996","unstructured":"Bullock BP, Heller RS, Habener JF. Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor. Endocrinology, 1996, 137: 2968-2978.","journal-title":"Endocrinology"},{"key":"null","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1161\/CIRCHEARTFAILURE.109.900282","volume":"3","author":"Bhashyam S","year":"2010","unstructured":"Bhashyam S, Fields AV, Patterson B, Testani JM, Chen L, Shen Y-T, Shannon RP. GLP-1 increases myocardial glucose uptake via p38\u03b1 MAP kinase mediated, nitric oxide dependent mechanisms in conscious dogs with dilated cardiomyopathy. Circ Heart Fail, 2010, 3: 512-521.","journal-title":"Circ Heart Fail"},{"key":"null","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1161\/CIRCHEARTFAILURE.108.766402","volume":"1","author":"Poornima I","year":"2008","unstructured":"Poornima I, Brown SB, Bhashyam S, Parikh P, Bolukoglu H, Shannon RP. Chronic glucagon-like peptide-1 infusion sustains left ventricular systolic function and prolongs survival in the spontaneously hypertensive, heart failure-prone rat. Circ Heart Fail, 2008, 1: 153-160.","journal-title":"Circ Heart Fail"},{"key":"null","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","volume":"375","author":"Marso SP","year":"2016","unstructured":"Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med, 2016, 375: 311-322.","journal-title":"N Engl J Med"},{"key":"null","first-page":"630537","volume":"2013","author":"Liu J","year":"2013","unstructured":"Liu J, Liu Y, Chen L, Wang Y, Li J. Glucagon-like peptide-1 analog liraglutide protects against diabetic cardiomyopathy by the inhibition of the endoplasmic reticulum stress pathway. J Diabetes Res, 2013, 2013:","journal-title":"J Diabetes Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.3892\/mmr.2014.1956","volume":"9","author":"Ji Y","year":"2014","unstructured":"Ji Y, Zhao Z, Cai T, Yang P, Cheng M. Liraglutide alleviates diabetic cardiomyopathy by blocking CHOP\u2011triggered apoptosis via the inhibition of the IRE-\u03b1 pathway. Mol Med Rep, 2014, 9: 1254-1258.","journal-title":"Mol Med Rep"},{"key":"null","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.mce.2017.03.029","volume":"448","author":"Zhang Y","year":"2017","unstructured":"Zhang Y, Ling Y, Yang L, Cheng Y, Yang P, Song X, Tang H. Liraglutide relieves myocardial damage by promoting autophagy via AMPK-mTOR signaling pathway in zucker diabetic fatty rat. Mol Cell Endocrinol, 2017, 448: 98-107.","journal-title":"Mol Cell Endocrinol"},{"key":"null","doi-asserted-by":"crossref","first-page":"H1007","DOI":"10.1152\/ajpheart.00563.2014","volume":"308","author":"Hao P-P","year":"2015","unstructured":"Hao P-P, Yang J-M, Zhang M-X, Zhang K, Chen Y-G, Zhang C, Zhang Y. Angiotensin-(1\u20137) treatment mitigates right ventricular fibrosis as a distinctive feature of diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol, 2015, 308: H1007-H1019.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"null","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1007\/s00125-012-2495-3","volume":"55","author":"Huynh K","year":"2012","unstructured":"Huynh K, Kiriazis H, Du X-J, Love J, Jandeleit-Dahm K, Forbes J, McMullen J. Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db\/db mouse model of type 2 diabetes. Diabetologia, 2012, 55: 1544-1553.","journal-title":"Diabetologia"},{"key":"null","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.2337\/db09-1456","volume":"59","author":"Huynh K","year":"2010","unstructured":"Huynh K, McMullen JR, Julius TL, Tan JW, Love JE, Cemerlang N, Kiriazis H. Cardiac-specific IGF-1 receptor transgenic expression protects against cardiac fibrosis and diastolic dysfunction in a mouse model of diabetic cardiomyopathy. Diabetes, 2010, 59: 1512-1520.","journal-title":"Diabetes"},{"key":"null","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1161\/CIRCULATIONAHA.112.091215","volume":"127","author":"Noyan-Ashraf MH","year":"2013","unstructured":"Noyan-Ashraf MH, Shikatani EA, Schuiki I, Mukovozov I, Wu J, Li R-K, Volchuk A. A glucagon-like peptide-1 analogue reverses the molecular pathology and cardiac dysfunction of a mouse model of obesity. Circulation, 2013, 127: 74-85.","journal-title":"Circulation"},{"key":"null","doi-asserted-by":"crossref","first-page":"e27861","DOI":"10.1371\/journal.pone.0027861","volume":"6","author":"Chaykovska L","year":"2011","unstructured":"Chaykovska L, von Websky K, Rahnenf\u00fchrer J, Alter M, Heiden S, Fuchs H, Runge F. Effects of DPP-4 inhibitors on the heart in a rat model of uremic cardiomyopathy. PLoS One, 2011, 6:","journal-title":"PLoS One"},{"key":"null","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jphs.2014.12.007","volume":"127","author":"Liu Y-S","year":"2015","unstructured":"Liu Y-S, Huang Z-W, Wang L, Liu X-X, Wang Y-M, Zhang Y, Zhang M. Sitagliptin alleviated myocardial remodeling of the left ventricle and improved cardiac diastolic dysfunction in diabetic rats. J Pharmacol Sci, 2015, 127: 260-274.","journal-title":"J Pharmacol Sci"},{"key":"null","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0945-053X(03)00006-4","volume":"22","author":"Myllyharju J","year":"2003","unstructured":"Myllyharju J. Prolyl 4-hydroxylases, the key enzymes of collagen biosynthesis. Matrix Biol, 2003, 22: 15-24.","journal-title":"Matrix Biol"},{"key":"null","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.tig.2003.11.004","volume":"20","author":"Myllyharju J","year":"2004","unstructured":"Myllyharju J, Kivirikko KI. Collagens, modifying enzymes and their mutations in humans, flies and worms. Trends Genet, 2004, 20: 33-43.","journal-title":"Trends Genet"},{"key":"null","doi-asserted-by":"crossref","first-page":"6654","DOI":"10.18632\/oncotarget.2208","volume":"5","author":"Chakravarthi BV","year":"2014","unstructured":"Chakravarthi BV, Pathi SS, Goswami MT, Cie\u015blik M, Zheng H, Nallasivam S, Arekapudi SR. The miR-124-prolyl hydroxylase P4HA1-MMP1 axis plays a critical role in prostate cancer progression. Oncotarget, 2014, 5:","journal-title":"Oncotarget"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/engine.scichina.com\/doi\/pdf\/6320719B67514AE4868BBDA7F3DCE4FA","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/engine.scichina.com\/doi\/10.1093\/abbs\/gmy177","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/engine.scichina.com\/doi\/pdf\/6320719B67514AE4868BBDA7F3DCE4FA","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T15:21:35Z","timestamp":1662736895000},"score":1,"resource":{"primary":{"URL":"http:\/\/engine.scichina.com\/doi\/10.1093\/abbs\/gmy177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,1]]},"references-count":27,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,2,19]]},"published-print":{"date-parts":[[2019,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/abbs\/gmy177","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2,1]]}}}